Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases?
about
The Community As the Patient in Malaria-Endemic Areas: Preempting Drug Resistance with Multiple First-Line TherapiesArtemether-Lumefantrine and Dihydroartemisinin-Piperaquine Exert Inverse Selective Pressure on Plasmodium Falciparum Drug Sensitivity-Associated Haplotypes in Uganda.Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in northern Angola.Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial.Fitness Consequences of Plasmodium falciparum pfmdr1 Polymorphisms Inferred from Ex Vivo Culture of Ugandan ParasitesIntermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.Randomised controlled trial of two sequential artemisinin-based combination therapy regimens to treat uncomplicated falciparum malaria in African children: a protocol to investigate safety, efficacy and adherence.Progress in paediatric parasitology: a preface to a topic focusing on ever younger subjects.
P2860
Q28551049-30E99E0E-AE96-4C9C-B47F-49ED72C2C1C8Q33629027-005E8C2B-B34D-46D6-A389-76C5160CB3ECQ34281680-50E20088-A5CA-4B9A-82AA-07116EF129FBQ36276785-1709497D-23A1-4D2C-9144-A717578600AFQ36812874-606903AB-F4F2-4CFB-8290-F82634BF31F9Q37124235-D67CA395-5A04-4D97-B1A4-1B4567512624Q37287899-04825E80-55A2-4E60-8978-09CCF0CA6509Q43923927-0062AAF4-DF51-4326-9DA6-44871871B409Q46326563-798BF4CB-055B-4F74-B934-75ABB2D109D6
P2860
Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Rational deployment of antimal ...... for paediatric malaria cases?
@ast
Rational deployment of antimal ...... for paediatric malaria cases?
@en
type
label
Rational deployment of antimal ...... for paediatric malaria cases?
@ast
Rational deployment of antimal ...... for paediatric malaria cases?
@en
prefLabel
Rational deployment of antimal ...... for paediatric malaria cases?
@ast
Rational deployment of antimal ...... for paediatric malaria cases?
@en
P2093
P2860
P1433
P1476
Rational deployment of antimal ...... for paediatric malaria cases?
@en
P2093
Badria Babiker El Sayed
Colin J Sutherland
Hamza Babiker
P2860
P304
P356
10.1017/S0031182011001144
P577
2011-08-03T00:00:00Z